Reducing racial and ethnic disparities in cardiovascular outcomes among cancer survivors.

IF 4.7 2区医学 Q1 ONCOLOGY

Current Oncology Reports Pub Date : 2024-10-01 Epub Date: 2024-07-13 DOI:10.1007/s11912-024-01578-7

Min Choon Tan, Nickolas Stabellini, Jia Yi Tan, Jia Yean Thong, Catherine Hedrick, Justin Xavier Moore, Jennifer Cullen, Anika Hines, Arnethea Sutton, Vanessa Sheppard, Neeraj Agarwal, Avirup Guha

{"title":"Reducing racial and ethnic disparities in cardiovascular outcomes among cancer survivors.","authors":"Min Choon Tan, Nickolas Stabellini, Jia Yi Tan, Jia Yean Thong, Catherine Hedrick, Justin Xavier Moore, Jennifer Cullen, Anika Hines, Arnethea Sutton, Vanessa Sheppard, Neeraj Agarwal, Avirup Guha","doi":"10.1007/s11912-024-01578-7","DOIUrl":null,"url":null,"abstract":"Purpose of review: Analyze current evidence on racial/ethnic disparities in cardiovascular outcomes among cancer survivors, identifying factors and proposing measures to address health inequities.Recent findings: Existing literature indicates that the Black population experiences worse cardiovascular outcomes following the diagnosis of both initial primary cancer and second primary cancer, with a notably higher prevalence of cardio-toxic events, particularly among breast cancer survivors. Contributing socioeconomic factors to these disparities include unfavorable social determinants of health, inadequate insurance coverage, and structural racism within the healthcare system. Additionally, proinflammatory epigenetic modification is hypothesized to be a contributing genetic variation factor. Addressing these disparities requires a multiperspective approach, encompassing efforts to address racial disparities and social determinants of health within the healthcare system, refine healthcare policies and access, and integrate historically stigmatized racial groups into clinical research. Racial and ethnic disparities persist in cardiovascular outcomes among cancer survivors, driven by multifactorial causes, predominantly associated with social determinants of health. Addressing these healthcare inequities is imperative, and timely efforts must be implemented to narrow the existing gap effectively.","PeriodicalId":10861,"journal":{"name":"Current Oncology Reports","volume":" ","pages":"1205-1212"},"PeriodicalIF":4.7000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Oncology Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11912-024-01578-7","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/13 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of review: Analyze current evidence on racial/ethnic disparities in cardiovascular outcomes among cancer survivors, identifying factors and proposing measures to address health inequities.

Recent findings: Existing literature indicates that the Black population experiences worse cardiovascular outcomes following the diagnosis of both initial primary cancer and second primary cancer, with a notably higher prevalence of cardio-toxic events, particularly among breast cancer survivors. Contributing socioeconomic factors to these disparities include unfavorable social determinants of health, inadequate insurance coverage, and structural racism within the healthcare system. Additionally, proinflammatory epigenetic modification is hypothesized to be a contributing genetic variation factor. Addressing these disparities requires a multiperspective approach, encompassing efforts to address racial disparities and social determinants of health within the healthcare system, refine healthcare policies and access, and integrate historically stigmatized racial groups into clinical research. Racial and ethnic disparities persist in cardiovascular outcomes among cancer survivors, driven by multifactorial causes, predominantly associated with social determinants of health. Addressing these healthcare inequities is imperative, and timely efforts must be implemented to narrow the existing gap effectively.

Abstract Image

查看原文本刊更多论文

减少癌症幸存者心血管疾病结果的种族和民族差异。

综述目的：分析癌症幸存者心血管疾病结果的种族/民族差异的现有证据，确定因素并提出解决健康不平等问题的措施：现有文献表明，黑人在确诊初次原发性癌症和第二次原发性癌症后，心血管疾病的治疗效果较差，尤其是在乳腺癌幸存者中，心毒性事件的发生率明显较高。造成这些差异的社会经济因素包括不利的社会健康决定因素、保险覆盖面不足以及医疗保健系统中的结构性种族主义。此外，促炎性表观遗传修饰被认为是导致遗传变异的一个因素。要解决这些差异问题，需要采取多角度的方法，包括努力解决医疗保健系统中的种族差异和健康的社会决定因素，完善医疗保健政策和获取途径，并将历史上被污名化的种族群体纳入临床研究。在癌症幸存者的心血管疾病治疗结果方面，种族和民族差异依然存在，这是由多因素造成的，主要与健康的社会决定因素有关。解决这些医疗保健不平等问题势在必行，必须及时采取措施，有效缩小现有差距。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Oncology Reports ONCOLOGY-

CiteScore

8.50

自引率

0.00%

发文量

187

审稿时长

6-12 weeks

期刊介绍： This journal aims to review the most important, recently published clinical findings in the field of oncology. By providing clear, insightful, balanced contributions by international experts, the journal intends to serve all those involved in the care of those affected by cancer. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as cancer prevention, leukemia, melanoma, neuro-oncology, and palliative medicine. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.